DJIA 17,131.86 47.37 0.28%
NASDAQ 4,838.64 8.17 0.17%
S&P 500 2,017.46 2.57 0.13%
market minute promo

ImmunoGen (NASDAQ: IMGN)

10.84 -0.07 (-0.64%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

IMGN $10.84 -0.64%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $11.06
Previous Close $10.91
Daily Range $10.49 - $11.16
52-Week Range $5.34 - $19.43
Market Cap $942.7M
P/E Ratio -15.37
Dividend (Yield) $0.00 (0.0%)
Volume 706,156
Average Daily Volume 1,552,476
Current FY EPS -$1.42




Drug Makers

ImmunoGen (IMGN) Description

ImmunoGen develops cancer therapeutics through its tumor-activated, prodrug technology, which targets antibodies with cancer-killing drugs. Website:

News & Commentary

Why Biotech Took a Beating Today

What goes up must come down.

Benzinga's Top Downgrades

Why ImmunoGen Fell 15% Today

ImmunoGen's shares are falling after its investor conference last week and amid an industry wide rout.

New Biotech Pair Trade: Infinity Pharma Over ImmunoGen

Mid-Morning Market Update: Markets Open Higher; Lennar Tops Q3 Views

Mid-Morning Market Update: Markets Open Higher; Lennar Tops Q3 Views

Immunogen (IMGN) Stock: Weak On High Volume Today

Friday's ETF with Unusual Volume: XBI

Why ImmunoGen Shares Are Falling Today

ImmunoGen investors are giving back yesterday's gains following the company's investor presentation today.

Immunogen (IMGN) In A Perilous Reversal

See More IMGN News...

IMGN's Top Competitors

IMGN $10.84 (-0.64%)
Current stock: IMGN
AMGN $153.04 (2.31%)
Current stock: AMGN
GILD $99.50 (-1.14%)
Current stock: GILD
BIIB $264.67 (-1.67%)
Current stock: BIIB